| Type: | Studiedocumentatie |
| Ziektebeelden: | Hodgkin lymfoom (HL) |
| Leeftijd: | ≥ 18 jaar |
| Fase: | Fase 3 |
| Lijn: | 1e lijn |
| Status: | Gesloten |
| Locatie: | Amsterdam UMC |
| Volledige titel | Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma; comparison of 6 cycles of escalated BEACOPP with 6 cycles of BrECADD advanced stage Hodgkin lymphoma; comparison of 4-6 cycles of escalated BEACOPP with 4-6 cycles of BrECADD |
| Documenten |
|
| Samenvatting met in- en exclusiecriteria | |
Veiligheidsinformatie |
|
| Niet geregistreerde geneesmiddelen | |
| Geregistreerde geneesmiddelen | |
| NB |
|
| Principal investigator Amsterdam UMC | Josée Zijlstra |
| Principal investigator elders | |